Literature DB >> 19213241

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.

A Jasovich1, M C Ganaha, C Ebi, R D García, M A Blanco, H Lopardo.   

Abstract

Enterococcus raffinosus is scarcely found in clinical samples and even less frequently as etiologic agent of endocarditis. We are herein presenting one case of mitral prosthetic-valve endocarditis in a 77-y-o male due to a vancomycin-resistant Enterococcus raffinosus isolate, successfully treated with 6 weeks of linezolid, and a two-year follow up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19213241

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  3 in total

1.  Enterococcus raffinosus bacteremia: clinical experience with 49 adult patients.

Authors:  Yun Woo Lee; So Yun Lim; Jiwon Jung; Min Jae Kim; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Yang Soo Kim; Sang-Ho Choi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-03       Impact factor: 3.267

2.  Enterococcus raffinosus, Enterococcus durans and Enterococcus avium Isolated from a Tertiary Care Hospital in Romania-Retrospective Study and Brief Review.

Authors:  Dan Alexandru Toc; Stanca Lucia Pandrea; Alexandru Botan; Razvan Marian Mihaila; Carmen Anca Costache; Ioana Alina Colosi; Lia Monica Junie
Journal:  Biology (Basel)       Date:  2022-04-14

3.  Linezolid for infective endocarditis: A structured approach based on a national database experience.

Authors:  P Muñoz; S De la Villa; M Martínez-Sellés; M A Goenaga; K Reviejo-Jaka; F Arnáiz de Las Revillas; L García-Cuello; C Hidalgo-Tenorio; M A Rodríguez-Esteban; I Antorrena; L Castelo-Corral; E García-Vázquez; J De la Torre; E Bouza
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.